World Health Organization Issues Warning Over Severe Shortage of Obesity Injections
Less than 10% of individuals who could benefit from weight-loss injections such as Wegovy are able to get them, caution the World Health Organization as it publishes its inaugural recommendations on the medications.
Considering in excess of 1,000,000,000 people worldwide currently classified as obese, it is advocating for more widespread and fairer availability to GLP-1 medication.
According to forecasts, more than two billion are projected to be living with obesity by 2030 unless action is taken.
"The new guidelines affirms that excess weight is a long-term condition that can be managed with thorough and ongoing treatment," remarked WHO director-general Tedros Adhanom Ghebreyesus.
Substantial prices, limited production capacity, and distribution challenges are key hurdles to broad access to the treatments that can aid individuals in losing considerable weight, says the agency.
Weight-Loss Drug Supply Crisis
Even under the present best projected scenario, the production of GLP-1 therapies could only cover approximately 100 million people – under 10% of eligible patients, per the health organization.
The guideline encourages nations and manufacturers to expand access, via measures including voluntary licensing.
The intellectual property rights on a key compound – the primary ingredient of Novo Nordisk's Wegovy – is set to lapse in several countries in 2026.
How Weight-Loss Jabs Function
The injections mimick a biological compound to reduce digestion speed, reduce hunger and boost feelings of fullness so people eat less.
Individuals typically begin shedding pounds in the initial weeks of beginning the once-weekly jabs.
Evidence indicates users may see weight return a year later of stopping the treatment, because their normal food cravings resume.
To be above a healthy weight raises your chance for experiencing health problems, like type 2 diabetes, heart disease, stroke, and certain malignancies.
Obesity concerns individuals in every country and was linked to millions of deaths worldwide in 2024, according to the WHO.
